Impress secures 40 million EIB loan for its clinical AI
Spanish start-up Impress, specialized in invisible orthodontics and medical technology, signed a 40 million euro venture debt loan with the European Investment Bank (EIB). The funds will boost its artificial intelligence platform across its network of more than 110 clinics and accelerate its expansion in Germany, the Netherlands and the United Kingdom. With this injection, the company founded in 2019 has raised 290 million in total. Over the past year it posted positive EBITDA and 32% revenue growth, to 103 million euros.
In 40 seconds
- The EIB grants Impress a 40 million euro venture debt loan.
- The funds will boost its clinical AI platform and expansion in Germany, the Netherlands and the UK.
- Impress operates in 10 countries with more than 110 clinics and has raised 290 million.
IASummary generated by artificial intelligence from a story by Cinco Días. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.